CoChat

Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications

Open access
Checa-Ros, Ana, Jeréz-Calero, Antonio, Molina-Carballo, Antonio, Campoy, Cristina, Muñoz-Hoyos, Antonio · 2021 · Nutrients

The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.

Abstract

Studies suggest that the bidirectional relationship existent between the gut microbiome (GM) and the central nervous system (CNS), or so-called the microbiome–gut–brain axis (MGBA), is involved in diverse neuropsychiatric diseases in children and adults. In pediatric age, most studies have focused on patients with autism. However, evidence of the role played by the MGBA in attention deficit/hyperactivity disorder (ADHD), the most common neurodevelopmental disorder in childhood, is still scanty and heterogeneous. This review aims to provide the current evidence on the functioning of the MGBA in pediatric patients with ADHD and the specific role of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in this interaction, as well as the potential of the GM as a therapeutic target for ADHD. We will explore: (1) the diverse communication pathways between the GM and the CNS; (2) changes in the GM composition in children and adolescents with ADHD and association with ADHD pathophysiology; (3) influence of the GM on the ω-3 PUFA imbalance characteristically found in ADHD; (4) interaction between the GM and circadian rhythm regulation, as sleep disorders are frequently comorbid with ADHD; (5) finally, we will evaluate the most recent studies on the use of probiotics in pediatric patients with ADHD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu13010249

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic diagram of the three pathways (nerve, neuroendocrine and immune) that configure the microbiome–gut–brain axis. CRH: corticotropin-releasing hormone; ACTH: adrenocorticotropic hormone; MC2-R: melanocortin receptor 2. CD4+ T cell: CD4-positive T cell.
Figure 1 Schematic diagram of the three pathways (nerve, neuroendocrine and immune) that configure the microbiome–gut–brain axis. CRH: corticotropin-releasing hormone; ACTH: adrenocorticotropic hormone; MC2-R: melanocortin receptor 2. CD4+ T cell: CD4-positive T cell.CC BY · PubMed Central
Figure 2 Bacterial taxonomic classification including the genera cited in this article according to the National Center for Biotechnology Information (NCBI) Taxonomy Database [161,162].
Figure 2 Bacterial taxonomic classification including the genera cited in this article according to the National Center for Biotechnology Information (NCBI) Taxonomy Database [161,162].CC BY · PubMed Central
Figure 3 Interaction between the gut microbiome and omega-3 PUFAs (polyunsaturated fatty acids), and effect on ADHD symptoms. The imbalance in the omega-3:omega-6 PUFA ratio leads to a state of neuroinflammation and a consequent disruption in the dopaminergic system (black arrows). Dopaminergic dysfunction is one of the main factors contributting to ADHD core symptoms. Alterations in the microbial composition have also been associated with ADHD symptoms, apparently via the influence of the gut microbiome on neurotransmission (microbiome–gut–brain axis (MGBA)). The administration of probiotics (green arrow) may boost the concentrations of omega-3 PUFAs. This would correct the omega-3:omega-6 imbalance and ultimately improve ADHD symptoms by stabilizing neuronal membranes, dopaminergic neurotransmission and reducing neuroinflammation. On the other hand, supplementation with eicosapentaenoic/docosahexanoic acids (EPA/DHA) (yellow arrow) could induce changes in the microbial composition that would be beneficial for ADHD symptoms, via dopaminergic neurotransmission regulation (MGBA).
Figure 3 Interaction between the gut microbiome and omega-3 PUFAs (polyunsaturated fatty acids), and effect on ADHD symptoms. The imbalance in the omega-3:omega-6 PUFA ratio leads to a state of neuroinflammation and a consequent disruption in the dopaminergic system (black arrows). Dopaminergic dysfunction is one of the main factors contributting to ADHD core symptoms. Alterations in the microbial composition have also been associated with ADHD symptoms, apparently via the influence of the gut microbiome on neurotransmission (microbiome–gut–brain axis (MGBA)). The administration of probiotics (green arrow) may boost the concentrations of omega-3 PUFAs. This would correct the omega-3:omega-6 imbalance and ultimately improve ADHD symptoms by stabilizing neuronal membranes, dopaminergic neurotransmission and reducing neuroinflammation. On the other hand, supplementation with eicosapentaenoic/docosahexanoic acids (EPA/DHA) (yellow arrow) could induce changes in the microbial composition that would be beneficial for ADHD symptoms, via dopaminergic neurotransmission regulation (MGBA).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–210 of 210

Cited by

See all 164

Metadata

Authors
Checa-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., & Muñoz-Hoyos, A.
Affiliations
  • Aston University (GB)
  • Department of Pediatrics, San Cecilio University Hospital, 18016 Granada, Spain
  • Department of Pediatrics, School of Medicine, University of Granada, 18016 Granada, Spain
  • Universidad de Granada (ES)
Corresponding author
Checa-Ros, Ana
Venue
Nutrients
Publisher
MDPI AG
Published
2021-01-16
Volume
13
Issue
1
Pages
249
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3123755715
Cited by
164
References
208
Citations by year
2026: 32 · 2025: 40 · 2024: 37 · 2023: 24 · 2022: 23 · 2021: 8
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
gut microbiota, attention deficit hyperactivity disorder, microbiome-gut-brain axis, omega-3 polyunsaturated fatty acids, ADHD pathophysiology, circadian rhythm, sleep disorders, probiotics, children with ADHD, neurodevelopmental disorders
MeSH terms
Gastrointestinal Microbiome, Adolescent, Adult, Animals, Attention Deficit Disorder with Hyperactivity, Brain, Child, Female, Humans, Male, Fatty Acids, Omega-3, Dietary Supplements, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.